Aura Biosciences Inc.

Last updated September 27, 2026

Organization details

Legal name
Aura Biosciences Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
AURA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001501796

Board of directors

Board connections

5 of this board's directors also sit on 7 other boards.

Network of Aura Biosciences Inc.'s board connections Alumis Inc. Alumis Inc. Bicara Therapeutics Inc. Bicara Therapeutics In... Innoviva Inc. Innoviva Inc. LeonaBio Inc. LeonaBio Inc. Mereo BioPharma Group plc Mereo BioPharma Group... Ocular Therapeutix Inc. Ocular Therapeutix Inc... Zentalis Pharmaceuticals Inc. Zentalis Pharmaceutica... Antony C. Mattessich Antony C. Mattessich David Michael Johnson David Michael Johnso... Jeremy Bender Jeremy Bender Natalie C. Holles Natalie C. Holles Sapna Srivastava Sapna Srivastava Aura Biosciences Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$40,061,655
14 sales by 7 insiders
Date Insider Transaction Shares Price Value
Jul 7, 2026 Jeremy Bender Director Grant or award +30,000 โ€” โ€”
Jul 1, 2026 Kilroy Conor Officer (See Remarks) Grant or award +14,858 โ€” โ€”
Jun 16, 2026 Anthony S. Gibney Officer (See Remarks) Open-market sale โˆ’12,824 $6.42 $82,330
Jun 11, 2026 Teresa Marie Bitetti Director Grant or award +15,000 โ€” โ€”
Jun 11, 2026 Sapna Srivastava Director Grant or award +15,000 โ€” โ€”
Jun 11, 2026 David Michael Johnson Director Grant or award +15,000 โ€” โ€”
Jun 11, 2026 Antony C. Mattessich Director Grant or award +15,000 โ€” โ€”
May 19, 2026 Natalie C. Holles Director, Officer (See Remarks) Grant or award +600,118 โ€” โ€”
May 19, 2026 Natalie C. Holles Director, Officer (See Remarks) Grant or award +553,844 โ€” โ€”
May 7, 2026 Matrix Capital Management Company, LP 10% owner Open-market sale โˆ’6,922,870 $5.64 $39,044,987
Apr 16, 2026 Kilroy Conor Officer (See Remarks) Open-market sale โˆ’11,738 $7.02 $82,401
Mar 2, 2026 Kilroy Conor Officer (See Remarks) Grant or award +62,339 โ€” โ€”
Mar 2, 2026 Anthony S. Gibney Officer (See Remarks) Grant or award +71,245 โ€” โ€”
Mar 2, 2026 Los Pinos Elisabet De Director, Officer (See Remarks) Grant or award +166,000 โ€” โ€”
Mar 2, 2026 Plavsic Mark Officer (Chief Technology Officer) Grant or award +62,339 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.